Organovo

3D printing has found its way into a number of industries, including health care and medical technology. Organovo Holdings Inc (NYSE: ONVO), in particular, is one of the companies researching how 3D-printed technology can be useful in medical fields. The company focuses on the design and...

As the 3D space shows signs of becoming less novelty and more mainstream, the idea of acquiring 3D startups does too. Here are five 3D startups, each with a unique niche, along with publicly traded companies that could have reason to be interested in acquiring them – someday. My Mini...

U.S. stocks were little changed as investors digested comments coming from head of the Federal Reserve Bank of St. Louis. The Fed's Jim Bullard said that the 2.9 percent decline in the first quarter GDP is “giving me heartburn.” Bullard added that the worse than expected figure...

U.S. stocks were unable to keep yesterday's momentum and ended the day sharply lower. The Dow suffered yet another triple digit decline with the S&P 500 and Nasdaq indices shedding more than one percent. In Ben Bernanke's final meeting as Fed chief, the FOMC tapered its monthly bond...

Technology has reached a critical point where machines have the power to harness life. A report from research firm Gartner, entitled “Predicts 2014: 3D Printing at the Inflection Point,” says bioprinted human organs will soon be a reality due to rapid advances in medical technology. "3D...

Organovo (NYSE: ONVO) closed nine percent lower on Tuesday after Citron Research published a blog post saying to avoid the stock. If you’ve never heard of Citron Research, it’s the brainchild of Andrew Left, an activist short seller who has passionate fans as well as equally passionate critics...